EZZ Life Science Holdings Ltd (AU:EZZ) — Market Cap & Net Worth
Market Cap & Net Worth: EZZ Life Science Holdings Ltd (EZZ)
EZZ Life Science Holdings Ltd (AU:EZZ) has a market capitalization of $18.97 Million (AU$26.81 Million) as of May 6, 2026. Listed on the AU stock exchange, this Australia-based company holds position #25175 globally and #1105 in its home market, demonstrating a -25.97% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying EZZ Life Science Holdings Ltd's stock price AU$0.57 by its total outstanding shares 47043200 (47.04 Million). Analyse EZZ Life Science Holdings Ltd operating cash flow efficiency to see how efficiently the company converts income to cash.
EZZ Life Science Holdings Ltd Market Cap History: 2021 to 2026
EZZ Life Science Holdings Ltd's market capitalization history from 2021 to 2026. Data shows change from $15.79 Million to $18.97 Million (-11.44% CAGR).
EZZ Life Science Holdings Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how EZZ Life Science Holdings Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.53x
EZZ Life Science Holdings Ltd's market cap is 1.53 times its annual revenue
Latest Price to Earnings (P/E) Ratio
15.18x
EZZ Life Science Holdings Ltd's market cap is 15.18 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $15.79 Million | $15.02 Million | $1.31 Million | 1.05x | 12.03x |
| 2022 | $11.78 Million | $37.14 Million | $3.63 Million | 0.32x | 3.25x |
| 2023 | $21.20 Million | $66.44 Million | $6.96 Million | 0.32x | 3.04x |
| 2024 | $102.19 Million | $66.87 Million | $6.73 Million | 1.53x | 15.18x |
Competitor Companies of EZZ by Market Capitalization
Companies near EZZ Life Science Holdings Ltd in the global market cap rankings as of May 6, 2026.
Key companies related to EZZ Life Science Holdings Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.67 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #364 globally with a market cap of $72.97 Billion USD.
- UCB SA (BR:UCB): Ranked #515 globally with a market cap of $51.41 Billion USD ( €43.97 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #570 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.67 Billion | $424.36 |
| #364 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.97 Billion | $702.27 |
| #515 | UCB SA | BR:UCB | $51.41 Billion | €231.00 |
| #570 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
EZZ Life Science Holdings Ltd Historical Marketcap From 2021 to 2026
Between 2021 and today, EZZ Life Science Holdings Ltd's market cap moved from $15.79 Million to $ 18.97 Million, with a yearly change of -11.44%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$18.97 Million | -59.57% |
| 2025 | AU$46.93 Million | -54.07% |
| 2024 | AU$102.19 Million | +382.02% |
| 2023 | AU$21.20 Million | +79.92% |
| 2022 | AU$11.78 Million | -25.38% |
| 2021 | AU$15.79 Million | -- |
End of Day Market Cap According to Different Sources
On May 6th, 2026 the market cap of EZZ Life Science Holdings Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.97 Million USD |
| MoneyControl | $18.97 Million USD |
| MarketWatch | $18.97 Million USD |
| marketcap.company | $18.97 Million USD |
| Reuters | $18.97 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About EZZ Life Science Holdings Ltd
EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consum… Read more